Kelly Gold

Kelly Gold is the CFO of CAMP4 Therapeutics. Ms. Gold joined CAMP4 in 2017 and has held roles of increasing responsibility leading the Business Development and Finance functions. She has extensive knowledge of CAMP4’s financial organization and experience leading business development, operations, accounting, investor relations, and corporate communications functions. Prior to joining CAMP4, Ms. Gold held various roles in corporate finance and business planning at Biogen, where she provided financial leadership for the company’s late-stage and marketed rare disease programs. Prior to Biogen, Ms. Gold worked in both the healthcare and Latin American investment banking groups at Deutsche Bank. Ms. Gold began her career as a mechanical engineer designing biocontainment systems for Biosafety Level 4 research facilities. She holds bachelor’s degrees in biochemistry and mechanical engineering from Queen’s University in Ontario, as well as an MBA from the MIT Sloan School of Management.